Matt Bettonville

Reed Jobs, an investor leading Yosemite, is driven by a personal mission to make cancer non-lethal after losing his father to the disease. Joined by Matt Bettonville, they discuss the need for affordable cancer drugs and the surprising effectiveness of digital health tools in improving survival rates. They explore the potential of synthetic control arms to reduce clinical trial costs and emphasize the critical importance of early detection. Reed and Matt also highlight the urgency of maintaining U.S. leadership in global healthcare innovation.